Citizens Maintains Market Outperform on Pharvaris, Raises Price Target to $75

Benzinga Newsdesk www.benzinga.com Positive 91.1%

Neg 0% Neu 0% Pos 91.1%

Citizens analyst Jonathan Wolleben maintains Pharvaris (NASDAQ:PHVS) with a Market Outperform and raises the price target from $74 to $75.